Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

13.9%

14 terminated/withdrawn out of 101 trials

Success Rate

86.0%

-0.5% vs industry average

Late-Stage Pipeline

30%

30 trials in Phase 3/4

Results Transparency

67%

58 of 86 completed trials have results

Key Signals

58 with results10 terminated4 withdrawn

Enrollment Performance

Analytics

N/A

49(57.6%)

Phase 4

25(29.4%)

Phase 3

5(5.9%)

Phase 2

3(3.5%)

Phase 1

2(2.4%)

Early Phase 1

1(1.2%)

85Total

N/A(49)

Phase 4(25)

Phase 3(5)

Phase 2(3)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (101)

Showing 20 of 101 trials

NCT06447233Completed

Patient Perspectives Medicaid Title XIX Sterilization Consent Form

Role: collaborator

NCT07044622Not ApplicableWithdrawn

Transcutaneous Electrical Nerve Stimulation (TENS) for Intrauterine Device (IUD) Insertion Pain

Role: collaborator

NCT05505435Phase 4Completed

Continuation of Subcutaneous and Intramuscular Depot Medroxyprogesterone Acetate in Post-abortion Patients

Role: collaborator

NCT03106454Phase 3Completed

Ovulation Incidence in Oral Contraceptive Users

Role: collaborator

NCT03978598Phase 4Completed

Breastfeeding Etonogestrel Implant Study

Role: collaborator

NCT05285605Completed

Advance Provision of Postpartum Emergency Contraception and Its Effects on Reproductive Autonomy

Role: collaborator

NCT05317468Not ApplicableCompleted

Assessing Satisfaction With Contraceptive Counseling Using Telephone Versus Video Telehealth Visits

Role: collaborator

NCT03181061Withdrawn

Determinants of Success, Characterizing the Facilitators of Integrated Abortion Provision

Role: collaborator

NCT05191238Not ApplicableTerminated

Intrauterine Device (IUD) Self Removal

Role: collaborator

NCT04651166Phase 2Completed

Effect of Prophylactic Tranexamic Acid on Bleeding Outcomes for Dilation and Evacuation

Role: collaborator

NCT04254081Phase 4Completed

Addition of Buprenorphine to Paracervical Block for Pain Control During Osmotic Dilator Insertion

Role: collaborator

NCT05119439Phase 4Terminated

Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks

Role: collaborator

NCT03868787Not ApplicableCompleted

Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During Cervical Dilator Placement Prior to Dilation and Evacuation

Role: collaborator

NCT04396730Phase 4Completed

Cannabidiol and Oral Contraceptive Pills: Exploring a Drug-Drug Interaction

Role: collaborator

NCT03030443Completed

Patient Preferences in Anesthesia for Abortion Care

Role: collaborator

NCT02213874Not ApplicableCompleted

The Influence of Trust in the Health Care System on Postpartum Contraceptive Choice

Role: collaborator

NCT03636451Phase 3Completed

Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o

Role: collaborator

NCT01763073Completed

Beliefs and Practice Intentions of Future Ob/Gyn Residents Regarding Reproductive Healthcare

Role: collaborator

NCT02866279Not ApplicableCompleted

Immediate Postpartum Contraceptive Implant Placement and Breastfeeding Success in Women at Risk for Low Milk Supply: A Non-inferiority Trial

Role: collaborator

NCT03092037Completed

Pharmacogenomics of Contraception: Genetic Variants and Etonogestrel Pharmacokinetics

Role: collaborator